Journal article

Associations of objectively assessed Physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: Findings from NHANES (2003-2006)

BM Lynch, CM Friedenreich, EAH Winkler, GN Healy, JK Vallance, EG Eakin, N Owen

Breast Cancer Research and Treatment | Published : 2011

Abstract

Physical activity reduces the risk of postmenopausal breast cancer through multiple inter-related biologic mechanisms; sedentary time may contribute additionally to this risk. We examined cross-sectional associations of objectively assessed physical activity and sedentary time with established biomarkers of breast cancer risk in a population-based sample of postmenopausal women. Accelerometer, anthropometric and laboratory data were available for 1,024 (n = 443 fasting) postmenopausal women in the U.S. National Health and Nutrition Examination Survey 2003-2006. Associations of quartiles of the accelerometer variables (moderate-to vigorousintensity activity, light-intensity activity and seden..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Canadian Institutes of Health Research


Funding Acknowledgements

All data used in this study were collected by the National Center for Health Statistics, Centers for Disease Control and Prevention. Lynch is supported by a National Health and Medical Research Council (NHMRC) Public Health Training Fellowship (#586727) and an Alberta Innovates-Health Solutions Fellowship; Friedenreich is supported by a Health Senior Scholar Award from the Alberta Heritage Foundation for Medical Research; Healy is supported by a NHMRC Public Health Training Fellowship (#569861); Vallance is supported by a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research and a New Investigator Award from the Canadian Institutes of Health Research; Eakin is supported by a NHMRC Senior Research Fellowship (#511001); Owen is supported by a NHMRC Program Grant (#569940), a NHMRC Senior Principal Research Fellowship (#1003 960) and by Research Infrastructure funding from Queensland Health.